全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

中医药治疗胃癌前病变的优势探讨
An Exploration of the Advantages of Traditional Chinese Medicine in Treating Precancerous Conditions of the Stomach

DOI: 10.12677/tcm.2024.1311462, PP. 3122-3127

Keywords: 胃癌前病变,中医药,病因病机,治疗
Precancerous Lesions of the Stomach
, Traditional Chinese Medicine, Pathogenesis and Mechanism, Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract:

胃癌前病变(Precancerous Lesions of Gastric Cancer, PLGC)是胃癌发生前的关键阶段,涵盖慢性萎缩性胃炎(Chronic Atrophic Gastritis, CAG)伴肠上皮化生和异型增生等情况。本文深入探讨中医药治疗胃癌前病变的优势,从病因病机、治疗方案等多方面展开详细论述,并参考《黄帝内经》及《素问》等中医经典,旨在为临床实践提供有力指导。
Precancerous Lesions of Gastric Cancer (PLGC) are a crucial stage in the development of gastric cancer, encompassing conditions such as chronic atrophic gastritis (CAG) with intestinal metaplasia and dysplasia. This article delves into the advantages of traditional Chinese medicine (TCM) in treating PLGC, providing a detailed discussion from the perspective of etiology and pathogenesis, as well as treatment plans. It also references classic Chinese medicine texts such as the Yellow Emperor’s Inner Canon and the Suwen to provide guidance for clinical practice.

References

[1]  Du, Y., Bai, Y., Xie, P., Fang, J., Wang, X., Hou, X., et al. (2014) Chronic Gastritis in China: A National Multi-Center Survey. BMC Gastroenterology, 14, Article No. 21.
https://doi.org/10.1186/1471-230x-14-21
[2]  de Vries, A.C., van Grieken, N.C.T., Looman, C.W.N., Casparie, M.K., de Vries, E., Meijer, G.A., et al. (2008) Gastric Cancer Risk in Patients with Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands. Gastroenterology, 134, 945-952.
https://doi.org/10.1053/j.gastro.2008.01.071
[3]  葛媛莎, 许博文, 李杰. 基于“五观辨治”体系论治胃“炎-癌”转化[J]. 中医杂志, 2024, 65(19): 1988-1993.
[4]  张倩, 吴佳丽, 陈婉珍, 等. 中医药干预胃“炎-癌转化”作用机制的研究进展[J]. 湖南中医杂志, 2024, 40(9): 217-223.
[5]  王立业, 张艳彬, 朱亚楠, 等. 益胃解毒方治疗慢性萎缩性胃炎的效果及对Cyclin E、Th17/Treg比值的影响分析[J]. 检验医学与临床, 2024, 21(18): 2728-2732.
[6]  班彦然, 方霜霜, 王琳, 等. 从“虚、滞、郁、瘀”病机理论探讨慢性萎缩性胃炎癌前病变微观辨治[J]. 北京中医药, 2024, 43(9): 990-995.
[7]  孙树申, 宋蕊, 华德芳, 等. 血清PGI、PGII、PGR结合G-17及Hp检测用于早期胃癌和癌前病变的鉴别价值[J]. 中国老年学杂志, 2024, 44(18): 4377-4380.
[8]  李盟, 赵迪, 杜燕青, 等. 参佛胃康治疗慢性萎缩性胃炎胃癌前病变作用机制研究[J]. 西部中医药, 2024, 37(9): 30-34.
[9]  宋聃, 王培龙, 赵婉彬. 胃黏膜菌群在胃癌发生过程中的动态变化研究[J]. 长治医学院学报, 2024, 38(4): 249-254.
[10]  舒幸, 李彬, 姜皓琪, 等. 促胰岛素抵抗膳食指数与胃癌前病变患病风险的病例对照研究[J]. 中华疾病控制杂志, 2024, 28(8): 944-949.
[11]  张高来, 闻新丽. 基于联合辨证论治胃癌前病变临床思维与经验[J]. 陕西中医, 2024, 45(8): 1101-1105.
[12]  王绍坡, 李佃贵, 马晓菲, 等. 浊毒理论指导慢性萎缩性胃炎胃癌前病变治疗近20年研究回顾[J]. 中华中医药杂志, 2024, 39(8): 4416-4418.
[13]  杨帅, 周斌. 基于“因虚生积”理论探讨胃癌前病变的中医病机演变及辨治[J]. 中华中医药杂志, 2024, 39(8): 4115-4118.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133